Your monthly compilation of regulatory news from around the globe. Follow the link to read March's edition from Kinapse.
A recently announced FDA pilot program suggests that the agency is taking steps towards implementing an equivalent to the EMA's policy 0070. US-based organisations should act now to prepare.
With the Life Sciences industry playing catch-up on AI, how are industry leaders narrowing the gap? John Cogan, Head of innovation, shares his views.
Want to learn the most efficient way to run a clinical trial anonymisation project? Read our step-by-step guide to achieving EMA policy 0070 compliance.
Is your Biopharmaceutical organisation ready for GDPR? Read on to learn what steps you need to take to ensure compliance with the new regulation.